← Leaderboards
R Scott McIvor
University Of Minnesota Twin Cities
$12,592,678
Attributed
$13,516,840
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,516,840 · 17
By mechanism
R01$5,293,418 · 3
R44$3,547,267 · 2
P01$1,672,632 · 3
R21$1,351,383 · 4
R43$1,076,287 · 3
R41$575,853 · 2
Top collaborators
- Jarryd Matthew Campbell1 shared
- Christiane S Hampe1 shared
- Eric Herbig1 shared
- Karen Kozarsky1 shared
- Branden S Moriarity1 shared
- Beau Richard Webber1 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Chester B Whitley$15,153,874
- Elsa G Shapiro$765,873
- Perry B Hackett$3,902,841
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyGene TransferMediatingCellsMouse ModelEffectivenessGenesHematopoietic Stem CellsClinical TrialsGene ExpressionVectorSleeping BeautyTransfection /Expression VectorProteinsIn VivoAnimalsBaseAnimal ModelIn VitroAllogenicTissuesImmuneInheritedLaboratory Mouse
Grant awards (55)
In vivo and ex vivo gene editing for Artemis-deficient SCID$420,771
R21 · FY2025 · AI · contact PI
Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease$384,999
R43 · FY2024 · AR
Transposon Engineered B Cell Therapy for Hunter Syndrome$466,804
R43 · FY2020 · NS
Targeted Genetic Therapy for Artemis-Deficient SCID$229,226
R21 · FY2020 · AI · contact PI
Targeted Genetic Therapy for Artemis-Deficient SCID$190,726
R21 · FY2019 · AI · contact PI
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis$224,484
R43 · FY2015 · GM · contact PI
Sleeping Beauty-Mediated microRNA Therapeutics for Metastatic Colorectal Cancer$198,360
R21 · FY2015 · CA · contact PI
Sleeping Beauty-Mediated microRNA Therapeutics for Metastatic Colorectal Cancer$165,300
R21 · FY2014 · CA · contact PI
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$479,265
R44 · FY2013 · HL · contact PI
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$570,317
R44 · FY2012 · HL · contact PI
AAV Mediated Gene Transfer to the CNS for MPS I$211,009
R41 · FY2012 · DK
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$716,704
R44 · FY2011 · HL · contact PI
Transposon Mediated Gene Therapy for Colorectal Cancer$290,882
R01 · FY2011 · CA · contact PI
Lentiviral gene therapy for mucopolysaccharidosis$364,844
R41 · FY2010 · DK · contact PI
Transposon Mediated Gene Therapy for Colorectal Cancer$301,442
R01 · FY2010 · CA · contact PI
Gene Therapy for Athabascan SCID$306,066
R01 · FY2009 · AI · contact PI
Transposon Mediated Gene Therapy for Colorectal Cancer$297,109
R01 · FY2009 · CA · contact PI
Transposon-Mediated Gene Therapy for Fanconi Anemia$566,484
R44 · FY2008 · HL · contact PI
Gene Therapy for Athabascan SCID$306,264
R01 · FY2008 · AI · contact PI
Transposon Mediated Gene Therapy for Colorectal Cancer$290,033
R01 · FY2008 · CA · contact PI
Methotrexate Resistance Gene Expression$285,130
R01 · FY2008 · CA · contact PI
GENE THERAPY FOR CEREBELLAR ATAXIA$202,420
P01 · FY2008 · HD · contact PI
Core--Viral vector$61,654
P01 · FY2008 · HD · contact PI
Transposon-Mediated Gene Therapy for Fanconi Anemia$564,735
R44 · FY2007 · HL · contact PI
Gene Therapy for Athabascan SCID$312,392
R01 · FY2007 · AI · contact PI
Transposon Mediated Gene Therapy for Colorectal Cancer$309,901
R01 · FY2007 · CA · contact PI
Methotrexate Resistance Gene Expression$285,130
R01 · FY2007 · CA · contact PI
Gene therapy for ataxia$200,540
P01 · FY2007 · HD · contact PI
Core--Viral vector$61,078
P01 · FY2007 · HD · contact PI
Sleeping Beauty-Mediated Gene Therapy for Hemophilia$649,762
R44 · FY2006 · HL · contact PI
Gene Therapy for Athabascan SCID$321,919
R01 · FY2006 · AI · contact PI
Methotrexate Resistance Gene Expression$293,645
R01 · FY2006 · CA · contact PI
Gene therapy for ataxia$189,989
P01 · FY2006 · HD · contact PI
Core--Viral vector$57,867
P01 · FY2006 · HD · contact PI
Methotrexate Resistance Gene Expression$300,713
R01 · FY2005 · CA
Gene therapy for ataxia$184,456
P01 · FY2005 · HD
Gene Therapy for Athabascan SCID$164,064
R01 · FY2005 · AI
Core--Viral vector$56,181
P01 · FY2005 · HD
Methotrexate Resistance Gene Expression$294,951
R01 · FY2004 · CA
Gene therapy for ataxia$179,085
P01 · FY2004 · HD
Core--Viral vector$54,546
P01 · FY2004 · HD
METHOTREXATE RESISTANCE GENE EXPRESSION$233,888
R01 · FY2003 · CA
METHOTREXATE RESISTANCE GENE EXPRESSION$233,888
R01 · FY2002 · CA
CORE--VECTOR FACILITY$0
P01 · FY2002 · CA
METHOTREXATE RESISTANCE GENE EXPRESSION$233,888
R01 · FY2001 · CA
Core--viral vector$106,204
P01 · FY2001 · HD
GENE THERAPY FOR ATAXIA$106,204
P01 · FY2001 · HD
GENE THERAPY FOR ATAXIA$0
P01 · FY2001 · HD
Core--viral vector$0
P01 · FY2001 · HD
CORE--VECTOR FACILITY$0
P01 · FY2001 · CA
METHOTREXATE RESISTANCE GENE EXPRESSION$232,113
R01 · FY2000 · CA
NOVEL VERTEBRATE TRANSPOSON VECTOR FOR GENE THERAPY$147,000
R21 · FY2000 · DK
GENE THERAPY FOR ATAXIA$106,204
P01 · FY2000 · HD
Core--viral vector$106,204
P01 · FY2000 · HD
CORE--VECTOR FACILITY$0
P01 · FY2000 · CA